Hunger Perception and Weight-Related Outcomes Following Use of a Leptin-Supporting Dietary Supplement
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorEfforia, Inc
About this trial
This study evaluates changes in hunger perception and body composition-related measures following daily use of a commercially available dietary supplement formulated to support leptin-related metabolic signaling. Adult participants will self-administer the supplement for 12 weeks and complete periodic self-reported assessments related to appetite, hunger, and weight-related outcomes. Participants serve as their own control, with comparisons made between baseline and follow-up measurements. The study is designed to generate preliminary, real-world evidence regarding supplement use in a general wellness context.
Eligibility criteria
Qualifiers
Adults aged 18 years or older
Willing to pay for study supplies and able to take the dietary supplement daily for 12 weeks
Willing to complete electronic questionnaires and self-reported measurements
Able to provide informed consent
Disqualifiers
Pregnant or breastfeeding individuals
Known allergy or sensitivity to any supplement ingredients
Use of medications or supplements that could interfere with appetite or weight without medical clearance
Any medical condition that would make participation unsafe, as determined by the participant
Trial design
Treatments tested in this trial
- Leptin Balance Formula
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov